遺伝子検査市場：製品タイプ、技術、用途、流通チャネル、エンドユーザー別-2025-2030年世界予測

遺伝子検査市場の2023年の市場規模は118億9,000万米ドルで、2024年には135億5,000万米ドル、CAGR14.01%で成長し、2030年には297億9,000万米ドルに達すると予測されています。

遺伝子検査市場は、技術の進歩と個別化医療の重視の高まりを特徴とする、複雑かつダイナミックな分野へと急速に変貌を遂げています。過去数年間で、この業界は従来の診断ツールを超えて、ハードウェアとソフトウェアが絡み合った能力を活用する最先端の調査手法を取り入れるようになりました。各社が技術革新を続ける中、斬新な検査プロトコルと堅牢な分析プラットフォームが統合され、効率と精度が最優先される洗練された市場環境への道が開かれました。

最近の動向は、遺伝子検査の範囲を拡大しただけでなく、その経済的・臨床的意義を再定義しています。病気の早期発見の合理化から予防ヘルスケア戦略の強化に至るまで、遺伝子検査市場は世界の健康イニシアチブの形成において極めて重要な役割を担っています。このイントロダクションでは、市場セグメンテーション、地域ダイナミックス、遺伝子診断を積極的に再定義している主要プレイヤーを詳細に調査します。スピード、正確性、信頼性が競合の優位性を左右する時代において、進化する情勢を理解することは、業界におけるリーダーシップの確保を目指す利害関係者にとって極めて重要です。

このエグゼクティブサマリーでは、まずこの分野を形成している変革的なシフトについて概説し、次にセグメンテーションと地域別インサイトの分析的内訳を示し、最後に業界の意思決定者に向けた的を絞った提言と説得力のある行動への呼びかけで締めくくる。

遺伝子検査における変革的シフトの推進

遺伝子検査業界は近年、いくつかの変革期を迎えており、ヘルスケア診断や個別化医療に対する企業の取り組み方を再構築しています。技術の進歩によるコスト削減は、遺伝子検査の日常臨床への統合を加速させました。DNAシーケンシングの革新は、バイオインフォマティクスのツールの強化とともに、迅速かつ包括的な検査法へのシフトを可能にし、所要時間を大幅に短縮し、結果の全体的な精度を向上させました。

こうしたシフトの重要な推進力となっているのが、データ管理を簡素化し、検査結果の普及を改善するデジタルヘルスプラットフォームの採用拡大です。レガシーシステムからクラウドベースのソリューションへの移行は、リアルタイムのデータ処理を可能にしただけでなく、患者とヘルスケアプロバイダーとの間のよりパーソナライズされた関わりを促しています。この進化は研究開発への多額の投資によって支えられており、遺伝子発現プロファイリングや精密診断における画期的な進歩をもたらしています。

もう一つの重要な動向は、遺伝学、腫瘍学、計算生物学といった分野の学際的専門知識の統合です。このような協力的なアプローチは、伝統的な検査室業務と先端技術の融合を助け、患者中心かつ科学的に確かな革新的ソリューションを生み出しています。市場が成熟を続ける中、革新的なテクノロジーと進化する臨床アプリケーションの相互作用は、現代の業界動向を先取りすることの重要性を強調しています。こうした変革的な変化は、技術的なマイルストーンであるだけでなく、この分野でより高い基準を設定し続ける業界リーダーが採用した適応戦略の証でもあります。

遺伝子検査市場の詳細なセグメンテーション分析

遺伝子検査市場のセグメンテーションは、急速に進化するこの業界の多面的な性質にレンズを提供します。製品イノベーションの観点からセグメンテーションを分析すると、市場は消耗品と機器、ソフトウェアとサービスの2つの主要カテゴリーにまたがって研究されていることがわかる。この2つの焦点は、精密なハードウェアと高度な分析が連動するバランスの取れたエコシステムを支えています。

さらに、検査タイプに基づく評価も広範囲に及んでいます。業界は検査能力を、新生児のスクリーニング検査とともに、キャリア検査や診断検査を含む様々な専門分野に区分しています。さらに、市場は、薬理ゲノミクスの革新、着床前処置、出生前検査、症候前検査、および予測検査の両方で大きな成長を遂げています。各検査タイプは、遺伝学的診断と治療的介入の信頼性を高める独自のデータポイントを提供します。

さらに、技術的なセグメンテーションは、遺伝子分析で展開される多様な方法論についての洞察を提供します。細胞遺伝学、DNA配列決定、遺伝子発現プロファイリングは、マイクロアレイやPCRのような高度なプラットフォームによって補完されています。このような技術スペクトルは、検査室が特定の診断ニーズに基づいて理想的な方法を選択できることを保証します。

アプリケーションベースのセグメンテーションは、自己免疫疾患、がん、慢性疾患、遺伝性疾患、神経変性課題を含むさまざまな臨床分野に焦点を当てることで、市場戦略をさらに多様化しています。市場戦略はまた、オフラインとオンラインの両方を考慮した流通チャネルにも影響されます。最後に、エンドユーザーのセグメンテーションに重点を置くことで、診断ラボ、家庭環境、病院や診療所など、さまざまな参加者を紹介しています。これらのセグメンテーションを組み合わせることで、包括的な視点が得られ、意思決定者は的を絞った戦略を採用し、市場参入を最大化するために必要な洞察を得ることができます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患および腫瘍性疾患の有病率と精密医療の必要性
    • 遺伝子検査に関する政府の取り組みと自己検査キットの普及
  • 抑制要因
    • 遺伝子検査の偽陽性と偽陰性に関する懸念
  • 機会
    • 遺伝子検査技術の継続的な調査と新開発
    • 遠隔医療とデジタルヘルスプラットフォームによる遺伝子検査の出現
  • 課題
    • 遺伝子検査に対する物流上の障壁とプライバシーの懸念
• 市場セグメンテーション分析
  • 製品：効率的なデータ管理と分析のためのソフトウェアとサービスの普及
  • 検査の種類：特定の疾患の診断を行うための診断検査に重点を置く
  • テクノロジー：正確な遺伝子同定と疾患診断のためのDNAシーケンシングへの移行が進む
  • 応用：がんの早期兆候を検出するための遺伝子検査の採用増加
  • 流通チャネル：オンラインプラットフォームでの遺伝子検査製品の展開
  • エンドユーザー：病院や診療所で病気の診断や治療計画のために遺伝子検査ソリューションを広く利用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 遺伝子検査市場：製品別

• 消耗品と機器
• ソフトウェアとサービス

第7章 遺伝子検査市場テストの種類別

• キャリアテスト
• 診断検査
• 新生児スクリーニング
• 薬理ゲノミクス
• 着床前検査
• 出生前検査
• 発症前および予測検査

第8章 遺伝子検査市場：技術別

• 細胞遺伝学
• DNAシーケンシング
• 遺伝子発現プロファイリング
• マイクロアレイ
• PCR

第9章 遺伝子検査市場：用途別

• 自己免疫疾患
• がん
• 慢性疾患
• 遺伝性疾患
• 神経変性疾患

第10章 遺伝子検査市場：流通チャネル別

• オフライン
• オンライン

第11章 遺伝子検査市場：エンドユーザー別

• 診断検査室
• ホーム設定
• 病院と診療所

第12章 南北アメリカの遺伝子検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の遺伝子検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの遺伝子検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Bruker Corporation
• Centogene N.V.
• Color Health, Inc.
• CooperSurgical Inc.
• Editas Medicine, Inc.
• Eugene Labs Pty Ltd.
• Eurofins Scientific SE
• F. Hoffmann-La Roche AG
• Fulgent Genetics, Inc.
• Gene by Gene, Ltd.
• GeneDx, LLC
• Illumina, Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings
• Living DNA Ltd.
• Macrogen, Inc.
• MyHeritage Ltd.
• Myriad Genetics, Inc.
• Natera, Inc.
• Newtopia Inc.
• PathogenDx Corporation
• PerkinElmer Inc.
• Qiagen N.V.
• Quest Diagnostics Incorporated
• Sanofi S.A.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. GENETIC TESTING MARKET MULTI-CURRENCY
• FIGURE 2. GENETIC TESTING MARKET MULTI-LANGUAGE
• FIGURE 3. GENETIC TESTING MARKET RESEARCH PROCESS
• FIGURE 4. GENETIC TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 23. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 28. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 29. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENETIC TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENETIC TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 58. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 90. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 96. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. FRANCE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 190. GERMANY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. ISRAEL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. ITALY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. ITALY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 199. ITALY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. ITALY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. ITALY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 202. ITALY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 208. NETHERLANDS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. NIGERIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 220. NORWAY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. POLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. POLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 223. POLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. POLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. POLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. POLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. QATAR GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. QATAR GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 229. QATAR GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. QATAR GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. QATAR GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 232. QATAR GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 238. RUSSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 244. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 256. SPAIN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. SWEDEN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 262. SWEDEN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. SWITZERLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 268. SWITZERLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. TURKEY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 274. TURKEY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 286. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 287. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 288. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Genetic Testing Market was valued at USD 11.89 billion in 2023 and is projected to grow to USD 13.55 billion in 2024, with a CAGR of 14.01%, reaching USD 29.79 billion by 2030.

The genetic testing market has rapidly transformed into a complex and dynamic field, characterized by technological advancements and a growing emphasis on personalized medicine. Over the past few years, this industry has moved beyond traditional diagnostic tools to embrace state-of-the-art methodologies that leverage the intertwined capabilities of hardware and software. As companies continue to innovate, the integration of novel testing protocols with robust analytical platforms has paved the way for a sophisticated market environment where efficiency and precision are paramount.

Recent developments have not only expanded the scope of genetic testing but also redefined its economic and clinical significance. From streamlining early detection of diseases to enhancing preventive healthcare strategies, the market has taken a pivotal role in shaping global health initiatives. This introduction sets the stage for an in-depth exploration of market segmentation, regional dynamics, and the key players that are actively redefining genetic diagnostics. In an era where speed, accuracy, and reliability dictate competitive advantage, understanding the evolving landscape becomes critical for stakeholders looking to secure leadership in the industry.

In this executive summary, we begin by outlining the transformative shifts shaping the field, followed by an analytical breakdown of segmentation and regional insights, and conclude with targeted recommendations and a compelling call-to-action for industry decision-makers.

Driving Transformative Shifts in Genetic Testing

The genetic testing landscape has undergone several transformative shifts over recent years, reshaping the way businesses approach healthcare diagnostics and personalized medicine. Cost reductions, driven by advancements in technology, have accelerated the integration of genetic testing into routine clinical practice. Innovations in DNA sequencing, along with enhanced bioinformatics tools, have enabled a shift towards rapid and comprehensive testing methods, substantially shortening turnaround times and improving the overall accuracy of results.

A critical driver in these shifts is the growing adoption of digital health platforms that simplify data management and improve test result dissemination. The transition from legacy systems to cloud-based solutions has not only enabled real-time data processing but also encouraged more personalized engagement between patients and healthcare providers. This evolution is supported by substantial investments in research and development, which have paved the way for breakthroughs in gene expression profiling and precision diagnostics.

Another pivotal trend involves the integration of multidisciplinary expertise from fields such as genetics, oncology, and computational biology. This collaborative approach has helped merge traditional laboratory practices with advanced technology, creating innovative solutions that are both patient-centric and scientifically robust. As the market continues to mature, the interplay between innovative technology and evolving clinical applications underlines the importance of staying ahead of modern industry trends. These transformative shifts represent not only technological milestones but are also a testament to the adaptive strategies adopted by industry leaders who continue to set higher standards in the field.

In-Depth Segmentation Analysis of the Genetic Testing Market

The segmentation of the genetic testing market provides a lens into the multifaceted nature of this rapidly evolving industry. Analyze the segmentation from a product innovation perspective reveals that the market is studied across two primary categories, spanning consumables and equipment as well as software and services. This dual focus supports a balanced ecosystem where precision hardware and advanced analytics operate in tandem.

Moreover, the evaluation based on test type is extensive. The industry segments its testing capabilities into various specialized areas involving carrier and diagnostic tests along with screenings for newborns. Furthermore, the market has seen significant growth in pharmacogenomic innovations, preimplantation procedures, and both prenatal and presymptomatic as well as predictive testing. Each test type contributes unique data points that collectively enhance the reliability of genetic diagnostics and therapeutic interventions.

In addition, the technological segmentation offers insight into the diverse methodologies deployed in genetic analysis. Cytogenetics, DNA sequencing, and gene expression profiling are complemented by advanced platforms such as microarrays and PCR. Such a technical spectrum ensures that laboratories can select ideal methods based on specific diagnostic needs.

Application-based segmentation further diversifies market strategies by focusing on a range of clinical areas including autoimmune disorders, cancer, chronic diseases, genetic disorders, and neurodegenerative challenges. Market strategies are also influenced by the distribution channels, which consider both offline and online modalities, thereby broadening accessibility. Finally, emphasis on end-user segmentation showcases an array of participants including diagnostic laboratories, home settings, and hospitals and clinics. Together, these layers of segmentation inform a well-rounded perspective, equipping decision-makers with the insights needed to adopt targeted strategies and maximize market reach.

Based on Product, market is studied across Consumables & Equipment and Software & Services.

Based on Test Type, market is studied across Carrier Testing, Diagnostic Testing, New Born Screening, Pharmacogenomics, Preimplantation Testing, Prenatal Testing, and Presymptomatic & Predictive Testing.

Based on Technology, market is studied across Cytogenetics, DNA Sequencing, Gene Expression Profiling, Microarrays, and PCR.

Based on Application, market is studied across Autoimmune Disorders, Cancer, Chronic Diseases, Genetic Disorders, and Neurodegenerative Diseases.

Based on Distribution Channel, market is studied across Offline and Online.

Based on End-User, market is studied across Diagnostic Laboratories, Home Setting, and Hospitals & Clinics.

Regional Market Dynamics Shaping the Genetic Testing Industry

Regional insights into the genetic testing market reveal distinctive trends and opportunities across key global zones. In the Americas, technological advancements have significantly boosted market growth through strengthened healthcare infrastructures and proactive public health policies. Developed healthcare systems, supported by solid governmental frameworks, have accelerated the adoption of genetic diagnostics, particularly in disease prevention and the personalization of medical treatments.

In the region encompassing Europe, the Middle East, and Africa, a blend of high-quality research, robust regulatory frameworks, and emerging market potential defines the landscape. European nations continue to lead in innovation through cutting-edge technological research, while countries in the Middle East and Africa are rapidly embracing genetic testing as part of broader health and diagnostic reforms. This region is witnessing enhanced collaboration between private and public entities to address both economic and clinical gaps in healthcare delivery.

Asia-Pacific is emerging as a formidable force, driven by rapid urbanization, increasing investments in healthcare innovation, and a rapidly growing middle class. The region benefits from significant government initiatives geared towards expanding and modernizing healthcare facilities, thereby fostering an environment conducive to the widespread application of genetic testing services. The varying pace of digital transformation across these regions underscores the importance of tailoring strategies to specific cultural, economic, and regulatory contexts. Collectively, these regional dynamics present a mosaic of promising opportunities for stakeholders aiming to leverage genetic testing technologies for sustainable growth.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insightful Analysis of Leading Companies in Genetic Testing

The competitive landscape of the genetic testing market is defined by an array of leading companies recognized for their contributions to innovation and technological advancements. Industry giants such as Abbott Laboratories and Agilent Technologies, Inc. have long been instrumental in developing sophisticated testing platforms, while companies like Becton, Dickinson and Company and Bio-Rad Laboratories, Inc. continue to push the boundaries of diagnostic precision through their integrated solutions. These leaders, alongside firms such as Bio-Techne Corporation and Bruker Corporation, have set new standards in both the reliability and scalability of genetic assays.

Centogene N.V. and Color Health, Inc. are also contributing to more targeted and accessible genetic testing, ensuring that breakthroughs in diagnosis are rapidly translated into clinical practice. CooperSurgical Inc. and Editas Medicine, Inc. exemplify the next wave of innovation by enhancing both surgical precision and gene-editing techniques. Meanwhile, smaller players like Eugene Labs Pty Ltd. and Eurofins Scientific SE are expanding market reach through localized expertise and nimble operational frameworks.

Other notable players including F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd. and GeneDx, LLC have carved niches by specializing in tailored diagnostic and therapeutic solutions. The vision of these companies is further supported by major contributions from industry leaders such as Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, and Living DNA Ltd., who continue to drive advancements in sequencing technology and genetic analytics. Additional notable participants such as Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., and PathogenDx Corporation round out the landscape. Pioneering efforts by PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Sanofi S.A., and Thermo Fisher Scientific Inc. further reinforce a competitive environment characterized by relentless technological progress and market-driven innovation. The collective influence of these companies not only shapes present market trends but also sets the stage for future advancements in genetic testing.

The report delves into recent significant developments in the Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Bruker Corporation, Centogene N.V., Color Health, Inc., CooperSurgical Inc., Editas Medicine, Inc., Eugene Labs Pty Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd., GeneDx, LLC, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Living DNA Ltd., Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., PathogenDx Corporation, PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Sanofi S.A., and Thermo Fisher Scientific Inc.. Actionable Recommendations to Drive Market Leadership

For industry leaders navigating the evolving genetic testing market, adopting a forward-thinking strategy is imperative. Decision-makers are advised to embrace technology integration as a focal point of growth, leveraging advancements in both hardware and analytical software to streamline testing processes. By investing in state-of-the-art diagnostic tools and fostering partnerships that promote innovation, companies can secure a competitive edge in a rapidly evolving healthcare ecosystem.

It is essential to ensure that research and development activities remain aligned with emerging market trends, particularly in areas like gene expression profiling, DNA sequencing, and advanced bioinformatics. An active focus on diversifying testing methods to cover a broader range of applications-including autoimmune disorders, cancer, and neurodegenerative diseases-can not only enhance diagnostic accuracy but also increase market penetration. Collaborations with technological firms and academic institutions can facilitate the development of robust testing protocols that meet stringent regulatory requirements while addressing unmet clinical needs.

Furthermore, regional tailoring of market strategies can amplify impact. Leaders should consider localized strategies to capitalize on the unique dynamics of the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions. By aligning operational frameworks with regional healthcare needs and regulatory landscapes, companies can optimize resource allocation and streamline market entry. Finally, enhancing the digital ecosystem through cloud-based analytics and tele-diagnostic services can further democratize access to high-quality genetic testing. These actionable recommendations are set to empower industry leaders to not only maintain but also extend their influence in this dynamic market.

Concluding Thoughts on the Future of Genetic Testing

In conclusion, the genetic testing market represents a blend of rapid technological innovation, expansive segmentation strategies, and regionally diverse opportunities. The progress made over the recent years is indicative of an industry that is transforming from a niche service into a mainstream component of personalized healthcare. The intricate interplay between emerging technologies and robust market segmentation ensures that the market remains vibrant, with competitive differentiation driven by both product innovation and strategic geographic targeting.

The analysis presented here underscores the importance of a well-rounded market approach-one that synergizes technological advancements with deep industry insights and regional trends. As the industry continues to evolve, staying adaptable and harnessing the potential of innovations ranging from advanced sequencing methods to integrated data analytics will determine the success of market leaders. The roadmap outlined in this summary provides comprehensive guidance that will support the sustained growth and strategic dominance of companies investing in genetic testing.

Looking forward, the momentum in research and development is likely to accelerate further breakthroughs, thereby expanding the clinical applications of genetic diagnostics. Decision-makers who invest in technology, nurture key partnerships, and integrate cross-regional strategies will be best positioned to lead in this forward-thinking market. The future of genetic testing is not only bright but poised for disruptive reinvention, creating endless possibilities for elevating healthcare outcomes through precision diagnostics.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of genetic and oncology disorders and the need for precision medicine
    • 5.1.1.2. Government initiatives for genetic testing and the rise of self-test kits
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns associated with false positives and negatives of genetic tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and new developments in genetic testing technologies
    • 5.1.3.2. Emergence of genetic testing with telehealth and digital health platforms
  • 5.1.4. Challenges
    • 5.1.4.1. Logistical barriers and privacy concerns to genetic testing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Penetration of software and services for efficient data management and analysis
  • 5.2.2. Test Type: Emphasis on diagnostic testing to perform a particular disease diagnosis
  • 5.2.3. Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis
  • 5.2.4. Application: Rising adoption of genetic testing to detect early signs of cancer
  • 5.2.5. Distribution Channel: Deployment of genetic testing products on online platforms
  • 5.2.6. End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genetic Testing Market, by Product

• 6.1. Introduction
• 6.2. Consumables & Equipment
• 6.3. Software & Services

7. Genetic Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Carrier Testing
• 7.3. Diagnostic Testing
• 7.4. New Born Screening
• 7.5. Pharmacogenomics
• 7.6. Preimplantation Testing
• 7.7. Prenatal Testing
• 7.8. Presymptomatic & Predictive Testing

8. Genetic Testing Market, by Technology

• 8.1. Introduction
• 8.2. Cytogenetics
• 8.3. DNA Sequencing
• 8.4. Gene Expression Profiling
• 8.5. Microarrays
• 8.6. PCR

9. Genetic Testing Market, by Application

• 9.1. Introduction
• 9.2. Autoimmune Disorders
• 9.3. Cancer
• 9.4. Chronic Diseases
• 9.5. Genetic Disorders
• 9.6. Neurodegenerative Diseases

10. Genetic Testing Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline
• 10.3. Online

11. Genetic Testing Market, by End-User

• 11.1. Introduction
• 11.2. Diagnostic Laboratories
• 11.3. Home Setting
• 11.4. Hospitals & Clinics

12. Americas Genetic Testing Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Genetic Testing Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Genetic Testing Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Sysmex and QIAGEN strengthen alliance to advance genetic testing innovation
  • 15.3.2. Labcorp Finalizes Acquisition of Key Invitae Assets in Strategic Expansion
  • 15.3.3. Labcorp and Ultima Genomics partnership advances affordable genomic insights for oncology testing
  • 15.3.4. MedGenome expands its influence through strategic acquisition in east India's genetic testing landscape
  • 15.3.5. Bruker Corporation Expanded Diagnostic Capabilities with EUR 870 Million Acquisition of ELITechGroup SAS, Enhancing Molecular and Microbial Testing
  • 15.3.6. Devyser AB Unveiled New Genetic Testing Products to Improve Cancer Risk Analysis
  • 15.3.7. Blueprint Genetics Oy Offers Advanced Testing Solutions for Informed Family Planning Decisions
  • 15.3.8. Kindbody Unveiled Affordable, High-Quality Genetic Testing Division Kindlabs for Enhanced Pregnancy Success
  • 15.3.9. Delve Bio, Inc. Secureed USD 35 Million Funding to Unveil Causes of Neurological Inflammation Through Advanced Pathogen Detection
  • 15.3.10. FBI Approved QIAGEN N.V.'s Advanced Forensic DNA Testing Workflow for Use in National Crime Database
  • 15.3.11. healthOme, Inc. Acquired Kailos Genetics, Inc., to Enhance Genetic Testing Services for Cancer Risk and Medication Safety
  • 15.3.12. BeautyMap Launched DNA-Based Skincare and Haircare Test In India
  • 15.3.13. CENTOGENE N.V. and Takeda Pharmaceutical Company Limited Extend Partnership to Enhance Diagnostic Testing for Rare Diseases Globally
  • 15.3.14. Invitae Corporation and Epic Systems Corporation Joined Forces to Streamline Genetic Test Results, Enhancing Access for Healthcare Providers
  • 15.3.15. Agilent Technologies Inc. Expanded Clinical Research Capabilities with Acquisition of Avida Biomed
• 15.4. Strategy Analysis & Recommendation
  • 15.4.1. Natera, Inc.
  • 15.4.2. F. Hoffmann-La Roche AG
  • 15.4.3. Thermo Fisher Scientific Inc.
  • 15.4.4. Illumina, Inc.

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. Bio-Techne Corporation
• 6. Bruker Corporation
• 7. Centogene N.V.
• 8. Color Health, Inc.
• 9. CooperSurgical Inc.
• 10. Editas Medicine, Inc.
• 11. Eugene Labs Pty Ltd.
• 12. Eurofins Scientific SE
• 13. F. Hoffmann-La Roche AG
• 14. Fulgent Genetics, Inc.
• 15. Gene by Gene, Ltd.
• 16. GeneDx, LLC
• 17. Illumina, Inc.
• 18. Invitae Corporation
• 19. Laboratory Corporation of America Holdings
• 20. Living DNA Ltd.
• 21. Macrogen, Inc.
• 22. MyHeritage Ltd.
• 23. Myriad Genetics, Inc.
• 24. Natera, Inc.
• 25. Newtopia Inc.
• 26. PathogenDx Corporation
• 27. PerkinElmer Inc.
• 28. Qiagen N.V.
• 29. Quest Diagnostics Incorporated
• 30. Sanofi S.A.
• 31. Thermo Fisher Scientific Inc.